Sunrise Technologies set to reject tender offer
This article was originally published in Clinica
Executive Summary
Sunrise Technologies is urging its shareholders to reject an unsolicited tender offer by Growth Capital Corporation for up to 2.3 million shares at $12.50 per share. Shares in the company currently stand at $12.25, compared with a year-high of $20.37 and a year-low of $2.75. Sunrise has around 46 million shares outstanding.